Orphazyme - Company announcement - Major shareholder announcement
Kurs
+37,00%
Kurs
+37,00%
Kalender
| Tid* | ||
| 2024-08-20 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-17 | - | X-dag ordinarie utdelning STRAP 0.00 DKK |
| 2024-04-11 | - | Årsstämma |
| 2024-04-04 | - | Bokslutskommuniké 2023 |
| 2023-12-06 | - | Split STRAP 1000:1 |
| 2023-11-02 | - | Extra Bolagsstämma 2023 |
| 2023-09-12 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-22 | - | X-dag ordinarie utdelning STRAP 0.00 DKK |
| 2023-05-17 | - | Årsstämma |
| 2023-04-25 | - | Bokslutskommuniké 2022 |
| 2022-09-26 | - | Kvartalsrapport 2022-Q2 |
| 2022-06-29 | - | Årsstämma |
| 2022-06-28 | - | X-dag ordinarie utdelning STRAP 0.00 DKK |
| 2022-06-07 | - | Bokslutskommuniké 2021 |
| 2022-02-15 | - | Extra Bolagsstämma 2022 |
| 2021-08-31 | - | Kvartalsrapport 2021-Q2 |
| 2021-03-26 | - | X-dag ordinarie utdelning STRAP 0.00 DKK |
| 2021-03-25 | - | Årsstämma |
| 2021-03-02 | - | Bokslutskommuniké 2020 |
| 2020-09-21 | - | Extra Bolagsstämma 2020 |
| 2020-08-28 | - | Kvartalsrapport 2020-Q2 |
| 2020-03-27 | - | X-dag ordinarie utdelning STRAP 0.00 DKK |
| 2020-03-26 | - | Årsstämma |
| 2020-02-28 | - | Bokslutskommuniké 2019 |
| 2020-01-25 | - | Extra Bolagsstämma 2019 |
| 2019-08-28 | - | Kvartalsrapport 2019-Q2 |
| 2019-03-28 | - | X-dag ordinarie utdelning STRAP 0.00 DKK |
| 2019-03-27 | - | Årsstämma |
| 2019-03-01 | - | Bokslutskommuniké 2018 |
| 2018-08-28 | - | Kvartalsrapport 2018-Q2 |
| 2018-04-13 | - | X-dag ordinarie utdelning STRAP 0.00 DKK |
| 2018-04-12 | - | Årsstämma |
| 2018-03-15 | - | Bokslutskommuniké 2017 |
Beskrivning
| Land | Danmark |
|---|---|
| Lista | Small Cap Copenhagen |
| Sektor | Hälsovård |
| Industri | Bioteknik |
2023-05-19 09:21:45
Company announcement
No. 10/2023
Orphazyme A/S
Ole Maaløes Vej 3
DK-2200 Copenhagen N
www.orphazyme.com
Company Registration No. 32266355
Copenhagen, Denmark, May 19, 2023 – Orphazyme A/S (ORPHA.CO) (the “Company”), hereby announces the receipt of notification pursuant to Section 38 of the Danish Capital Markets Act from Scandinavian Investment Group A/S, that as of May 16, 2023, Scandinavian Investment Group A/S holds shares corresponding to 10.00% of the total share capital and voting rights in the Company.
For additional information, please contact
Orphazyme A/S
Michael Hove, Chairman of the board +45 28 12 66 09